Skip to main content
Glama

Oqmd

by io.github.pipeworx-io

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and non-destructive. The description adds valuable behavior context: pulls from SEC EDGAR/XBRL and FAERS, handles off-calendar fiscal years, sorts by primary metric, and returns paired data with citation URIs. No contradictions with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is longer but every sentence adds indispensable context. It front-loads user-intent examples then explains scope, data sources, and output, with no redundant or filler content.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite lacking an output schema, the description adequately explains return contents ('paired data + pipeworx:// citation URIs per entity'), data sources, and edge-case handling (off-calendar fiscal years). This is complete enough for an agent to select and invoke the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% and both parameters have descriptions. The description enriches 'type' and 'values' with concrete examples (AAPL, MSFT, ozempic), clarifies that company values are tickers/CIKs and drug values are names, and explains how results are sorted by primary metric, adding value beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states it performs 'side-by-side comparison of 2–5 companies or drugs' with a specific verb and resource. It distinguishes itself from sequential lookups and aligns with the 'compare' trigger phrases, making its purpose unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'ALWAYS PREFER over sequential single-pack lookups when comparing entities', giving a direct when-to-use directive and naming the alternative. It also lists multiple query formulations that should invoke this tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Oqmd toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Many tools overlap in purpose: ask_pipeworx, ask_pipeworx_grounded, and deep_research all answer questions; multiple prediction market tools (polymarket_edges, polymarket_arbitrage, polymarket_edge_tracker, polymarket_fill_risk) have subtle distinctions. An agent would struggle to choose correctly among these.

Naming Consistency4/5

Tool names follow a consistent snake_case verb_noun pattern (e.g., list_subscriptions, generate_llms_txt). A few are noun phrases (stable_phases) but the style is uniform and predictable.

Tool Count2/5

33 tools is high for a single server, especially given the mix of two unrelated domains (materials database and general data querying). Many prediction market tools could be consolidated, and the broad scope suggests over-engineering.

Completeness3/5

The materials data side covers search and retrieval adequately. The query side offers many capabilities but has redundant paths (e.g., multiple ways to ask questions) and gaps in editing or updating data. Overall coverage is mixed.

Resources